Investec Bank plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure, filed on 3rd August 2026, covers trading activity that took place on 31st July 2026 in Advanced Medical Solutions Group ordinary shares.
Investec Bank plc acted in its capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity during the disclosed period.
The bank holds a notable advisory relationship with the company, serving as Advisor and Joint Broker to Advanced Medical Solutions Group plc at the time of the dealings.
In terms of purchases, Investec Bank acquired 358,730 ordinary shares, with prices ranging from a low of 280 pence per unit to a high of 280.25 pence per unit.
On the sell side, the bank disposed of 431,803 ordinary shares, also transacting within the same price range of 280 to 280.25 pence per unit.
The volume of sales exceeded purchases during the session, with the bank selling approximately 73,000 more shares than it bought across the two transactions.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this regulatory disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or any formal or informal understandings that may have served as an inducement to deal or refrain from dealing.
The bank also confirmed no agreements or understandings exist relating to voting rights or the future acquisition and disposal of relevant securities tied to any derivative instrument.
The contact named on the disclosure is Abhishek Gawde, and the filing was submitted in compliance with public disclosure obligations under Rule 8 of the Takeover Code.
Rule 8 disclosures of this type are required to be made to a Regulatory Information Service to ensure transparency during offer periods involving publicly listed companies.
